## CPT: Camden Property Trust - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 0.8% below STRENGTH zone (3.0-6.0%); PEG 8.96 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-6.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($104.31)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Is Camden Property Trust (CPT) One of the Best Dividend Stocks in the Real Estate Sector?**
- Source: MSN | 20251221T210818 | Bullish | Relevance: 100%
- This article evaluates Camden Property Trust (CPT) as a dividend stock in the real estate sector. It analyzes the company's dividend history, growth, and payout ratio to determine if it's a good investment for income-seeking investors. The piece explores CPT's financial health and market position within the real estate industry.

**2. Camden Property Trust (CPT): Reassessing Valuation After Dual Listing, 2025 Guidance Upgrade and JP Morgan Rating Boost**
- Source: Simply Wall Street | 20251221T180817 | Bullish | Relevance: 100%
- Camden Property Trust (CPT) has recently experienced three positive catalysts: a dual listing on the NYSE Texas, an upgraded 2025 guidance, and a JP Morgan rating boost, which are collectively influencing its valuation. Despite a negative year-to-date share price return, the company shows strong long-term momentum and is considered modestly undervalued with a narrative fair value of $116.67, driven by operational improvements and capital discipline. However, some valuation models suggest it might be pricey compared to peers, trading at 42.5 times earnings.

**3. Thrivent Financial for Lutherans Raises Position in Camden Property Trust $CPT**
- Source: MarketBeat | 20251223T104601 | Somewhat-Bullish | Relevance: 100%
- Thrivent Financial for Lutherans increased its stake in Camden Property Trust (NYSE:CPT) by 426.0% in the second quarter, bringing their total holdings to 21,994 shares valued at $2.479 million. Numerous other institutional investors also adjusted their positions in the real estate investment trust. Analysts have largely maintained a "Hold" rating on CPT, with a consensus price target of $116.81, following recent earnings and dividend announcements.

**4. Camden Property Trust (CPT): Reassessing Valuation After Dual Listing, 2025 Guidance Upgrade and JP Morgan Rating Boost**
- Source: Simply Wall Street | 20251221T182947 | Somewhat-Bullish | Relevance: 100%
- Camden Property Trust (CPT) experienced three recent positive catalysts: a new NYSE Texas dual listing, upgraded 2025 guidance, and a JP Morgan rating increase, influencing investor perception. Despite a negative year-to-date share price return, its five-year total shareholder return indicates long-term momentum. The stock is considered 8.1% undervalued with a fair value of $116.67, driven by operating efficiency and capital management, though valuation models show it trading higher than peers based on its P/E ratio.

**5. 3 Residential REITs to Consider for Steady Income in 2026**
- Source: TradingView — Track All Markets | 20251223T140735 | Bullish | Relevance: 92%
- Despite a recent deceleration in U.S. apartment demand and persistent rent cuts, the long-term outlook for residential REITs remains healthy due to factors like unaffordable homeownership and easing supply. This article highlights three specific residential REITs—Essex Property Trust (ESS), UDR, Inc. (UDR), and Camden Property Trust (CPT)—as promising options for steady income in 2026. These companies are well-positioned for growth, supported by diverse portfolios, strategic market exposure, and favorable demographic trends.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | JP Morgan | $116 | $0 | 0% |
| 2025-12-15 | Truist Securiti | $116 | $123 | -6% |
| 2025-11-25 | Wells Fargo | $110 | $111 | -1% |
| 2025-11-25 | Barclays | $118 | $127 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | JP Morgan | up | Neutral |
| 2025-12-15 | Truist Securiti | main | Buy |
| 2025-11-25 | Wells Fargo | main | Equal-Weight |
| 2025-11-25 | Barclays | down | Equal-Weight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 56.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 16.0% (-0.5%)
- Blackrock Inc.: 10.8% (+3.2%)
- State Street Corpora: 7.1% (+1.5%)
- FMR, LLC: 5.1% (+17.5%)
- Viking Global Invest: 3.6% (+41.6%)

### Key Risks

1. Valuation stretched: PEG 9.0x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 8.96 signals overvaluation risk, limited margin of safety. Forward P/E 80.6x stretched relative to 17% growth. Quality metrics strong (margin 17%). Analyst sentiment negative (4 target cuts vs 0 raises). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.5B |
| Beta | 0.82 |
| 52W Range | $97.17 - $126.55 |
| Short Interest | 3.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 8.96 |
| Forward P/E | 80.6 |
| Current P/E | 94.6 |
| YoY Growth | 17.4% |
| EPS Direction | None |

### Technicals

MRS_10 deteriorating from 7.3% to 0.8% (-6.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.2pp (needs >3.0% for momentum thesis). MRS_5 (-1.6%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.98x), long-term trend not supportive. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.76% (CS: 83) | Neutral |
| RSI_14 | 61.5 | Neutral |
| MACD Histogram | 0.39 | Bullish |
| vs SMA20 | 1.022x | Above |
| vs SMA50 | 1.041x | Above |
| vs SMA200 | 0.976x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $107.81
- **Stop Loss:** $104.31 (3.2% risk)
- **Target:** $111.31 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 171
- **Position Value:** $18,435.51
- **Portfolio %:** 18.44%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-05 (Est: $0.28)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.28 | $0.21 | -23.2% |
| 2025Q2 | $0.33 | $0.31 | -6.9% |
| 2025Q1 | $0.28 | $0.36 | +29.5% |
| 2024Q4 | $0.42 | $0.37 | -11.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*